P
Passage Bio D
D
PASG
0.66320
USD
0.02
(2.92%)
Market Closed
Volume
1,000
EPS
0
Div Yield
0
P/E
-0
Market Cap
40,964,064
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Passage Bio
Sector: Healthcare
Industry: Biotechnology
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.